You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol

Article info

Article menu

Download PDFPDF

XML
Pleural Disease
Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol

Authors

  • Siao Nge Hoon Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, AustraliaCurtin Medical School, Curtin University, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Katrina Fyfe Curtin Medical School, Curtin University, Perth, Western Australia, AustraliaInstitute of Respiratory Health, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Carolyn J Peddle-McIntyre Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, AustraliaInstitute of Respiratory Health, Nedlands, Western Australia, AustraliaExercise Medicine Research Institute, Edith Cowan University—Joondalup Campus, Joondalup, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Samantha Bowyer Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Felicity Hawkins Palliative Care, Sir Charles Gairdner Hospital, Nedlands, Western Australia, AustraliaSchool of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Emily Jeffery School of Public Health, Curtin University, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Hui Jun Chih School of Public Health, Curtin University, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Jenette Creaney School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Anna Nowak Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, AustraliaSchool of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Fraser Brims Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, AustraliaCurtin Medical School, Curtin University, Perth, Western Australia, AustraliaInstitute of Respiratory Health, Nedlands, Western Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Fraser Brims; fraser.brims{at}curtin.edu.au
View Full Text

Citation

Hoon SN, Fyfe K, Peddle-McIntyre CJ, et al
Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol
BMJ Open Respiratory Research 2020;7:e000551. doi: 10.1136/bmjresp-2019-000551

Publication history

  • Received December 19, 2019
  • Revised January 31, 2020
  • Accepted February 9, 2020
  • First published March 25, 2020.
Online issue publication 
November 15, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.